Journalartikel

Multivalent stimulation of beta1-, but not beta2-receptors by adrenaline functionalised gold nanoparticles


AutorenlisteMattern, Annabelle; Claßen, Rebecca; Wolf, Annemarie; Pouokam, Ervice; Schlüter, Klaus-Dieter; Wickleder, Mathias S.; Diener, Martin

Jahr der Veröffentlichung2022

Seiten3182-3193

ZeitschriftNanoscale Advances

Bandnummer4

Heftnummer15

ISSN2516-0230

Open Access StatusGold

DOI Linkhttps://doi.org/10.1039/d2na00171c

VerlagRoyal Society of Chemistry


Abstract
In this study, we present a strategy for the synthesis of catecholamine functionalised gold nanoparticles and investigated their multivalent interactions with adrenergic receptors in different biological systems. The catecholamines adrenaline and noradrenaline represent key examples of adrenergic agonists. We used gold nanoparticles as carriers and functionalised them on their surface with a variety of these neurotransmitter molecules. For this purpose, we synthesised each ligand separately using mercaptoundecanoic acid as a bifunctional linking unit and adrenaline (or noradrenaline) as a biogenic amine. This ligand was then immobilised onto the surface of presynthesised spherical monodispersive gold nanoparticles in a ligand exchange reaction. After detailed analytical characterisations, the functionalised gold nanoparticles were investigated for their interactions with adrenergic receptors in intestinal, cardiac and respiratory tissues. Whereas the contractility of respiratory smooth muscle cells (regulated by beta(2)-receptors) was not influenced, (nor)adrenaline functionalised nanoparticles administered in nanomolar concentrations induced epithelial K+ secretion (mediated via different beta-receptors) and increased contractility of isolated rat cardiomyocytes (mediated by beta(1)-receptors). The present results suggest differences in the accessibility of adrenergic agonists bound to gold nanoparticles to the binding pockets of different beta-receptor subtypes.



Zitierstile

Harvard-ZitierstilMattern, A., Claßen, R., Wolf, A., Pouokam, E., Schlüter, K., Wickleder, M., et al. (2022) Multivalent stimulation of beta1-, but not beta2-receptors by adrenaline functionalised gold nanoparticles, Nanoscale Advances, 4(15), pp. 3182-3193. https://doi.org/10.1039/d2na00171c

APA-ZitierstilMattern, A., Claßen, R., Wolf, A., Pouokam, E., Schlüter, K., Wickleder, M., & Diener, M. (2022). Multivalent stimulation of beta1-, but not beta2-receptors by adrenaline functionalised gold nanoparticles. Nanoscale Advances. 4(15), 3182-3193. https://doi.org/10.1039/d2na00171c



Schlagwörter


CATECHOL OXIDATIONDRUG-DELIVERYVIVO PHOTODYNAMIC THERAPY


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 11:41